Variability in guideline-directed medical therapy among sites and operators and patient factors associated with its usage following carotid artery stenting
Authors:
- Dhruv KansalDKDhruv Kansal
- Yasser JamilYJYasser Jamil
- Mamadou JallowMJMamadou Jallow
- Gaëlle RomainGRGaëlle Romain
- Kim G. SmolderenKSKim G. Smolderen
- Carlos Mena-HurtadoCMCarlos Mena-Hurtado
Open Access
- 5 May 2026
- journal article
- Published by Elsevier in JVS-Vascular Insights
- Vol. 4
Abstract
No abstract availableFunding Information
- Merck
- National Institutes of Health (R01HL163640-02S1)
- National Institutes of Health (R21AT012430-01)
This publication has 25 references indexed in Scilit:
- Real-world use of medical therapy in moderate asymptomatic carotid stenosisJournal of Vascular Surgery, 2024
- Barriers to Antiplatelet and Statin Adherence Following Major Vascular InterventionAnnals of Vascular Surgery, 2024
- Real-World Outcomes of Carotid Artery Stenting in Symptomatic and Asymptomatic Patients With Carotid Artery StenosisJACC: Cardiovascular Interventions, 2024
- Antiplatelet regimens following carotid artery revascularizationAmerican Heart Journal, 2022
- Carotid Artery StentingJACC, 2022
- Validation of an indirect linkage algorithm to combine registry data with Medicare claimsJournal of Vascular Surgery, 2022
- The Society for Vascular Surgery implementation document for management of extracranial cerebrovascular diseaseJournal of Vascular Surgery, 2022
- Effects of statin and antiplatelet therapy noncompliance and intolerance on patient outcomes following vascular surgeryJournal of Vascular Surgery, 2020
- Age but not sex is associated with higher risk of in-hospital stroke or death after carotid artery stenting in symptomatic and asymptomatic carotid stenosisJournal of Vascular Surgery, 2019
- ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery DiseaseJACC, 2018